日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic decoding of drug-resistant tuberculosis transmission in Thailand over three decades

三十年来泰国耐药结核病传播的基因组解码

Thawong, Naphatcha; Srilohasin, Prapaporn; Phelan, Jody E; Phornsiricharoenphant, Worawich; Tongsima, Sissades; Suriyaphol, Prapat; Prammananan, Therdsak; Faksri, Kiatichai; Sawaengdee, Waritta; Wang, Linfeng; Hinthong, Woranich; Hibberd, Martin L; Campino, Susana; Wattanapokayakit, Sukanya; Mahasirimongkol, Surakameth; Chaiprasert, Angkana; Clark, Taane G

Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand

泰国SARS-CoV-2异源启动和加强免疫反应的血清学见解

Ward, Daniel; Pattarapreeyakul, Lapasrada; Pitaksalee, Rujiraporn; Thawong, Naphatcha; Sawaengdee, Waritta; Tuntigumthon, Suthida; Patterson, Catriona; Tetteh, Kevin; Campino, Susana; Dhepakson, Panadda; Mahasirimongkol, Surakameth; Clark, Taane G

TOAST: a novel tool for designing targeted gene amplicons and an optimised set of primers for high-throughput sequencing in tuberculosis genomic studies

TOAST:一种用于设计靶向基因扩增子和优化引物组的新工具,适用于结核病基因组研究中的高通量测序。

Wang, Linfeng; Thawong, Naphatcha; Thorpe, Joseph; Higgins, Matthew; Ik, Mark Tan Kia; Sawaengdee, Waritta; Mahasirimongkol, Surakameth; Perdigão, João; Campino, Susana; Clark, Taane G; Phelan, Jody E

SARS-CoV-2 Seroprevalence in Unvaccinated Adults in Thailand in November 2021

2021年11月泰国未接种疫苗成年人中SARS-CoV-2血清阳性率

Mahasirimongkol, Surakameth; Uppapong, Ballang; Puangtubtim, Wiroj; Dhepakson, Panadda; Panyajai, Parnuphan; Thawong, Naphatcha; Pinyosukhee, Nadthanan; Rojanawiwat, Archawin; Wichukchinda, Nuanjun; Soonthorncharttrawat, Sakulrat; Larpardisorn, Kanisorn; Amonyingcharoen, Sumet; Juntaped, Kritchai; Chaiyakum, Tassanee; Tongkamsen, Chayada; Srilaket, Jeerapa; Chipatoom, Jiratikamon; Wichajarn, Rattanawadee; Chatchawankanpanich, Nutchanat; Pattarapreeyakul, Lapasrada; Chaiya, Porntip; Mongkolsiri, Kaveewan; Tuntigumthon, Suthida; Sophondilok, Kritsamon; Saengtong, Nalinee; Jongpitisub, Kodcharad; Sirilak, Supakit

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine

新冠病毒疫苗接种方案免疫原性和不良事件的试点研究:先接种灭活全病毒SARS-CoV-2疫苗(CoronaVac),再接种腺病毒载体(ChAdOx1 nCoV-19)疫苗

Mahasirimongkol, Surakameth; Khunphon, Athiwat; Kwangsukstid, Oraya; Sapsutthipas, Sompong; Wichaidit, Mingkwan; Rojanawiwat, Archawin; Wichuckchinda, Nuanjun; Puangtubtim, Wiroj; Pimpapai, Warangluk; Soonthorncharttrawat, Sakulrat; Wanitchang, Asawin; Jongkaewwattana, Anan; Srisutthisamphan, Kanjana; Phainupong, Daraka; Thawong, Naphatcha; Piboonsiri, Pundharika; Sawaengdee, Waritta; Somsaard, Thitiporn; Ritthitham, Kanokphon; Chumpol, Supaporn; Pinyosukhee, Nadthanan; Wichajarn, Rattanawadee; Dhepakson, Panadda; Iamsirithaworn, Sopon; Phumiamorn, Supaporn